Phapros Tbk Financials

PEHA Stock  IDR 304.00  6.00  2.01%   
We recommend to use Phapros Tbk PT fundamental analysis to see if markets are presently undervaluing or overvaluing the firm. Put it differently, this technique allows you to confirm available drivers of Phapros Tbk PT as well as the relationship between them. We were able to collect data for thirty available financial ratios for Phapros Tbk PT, which can be compared to its competitors. The stock experiences an unexpected upward trend. Watch out for market signals. Check odds of Phapros Tbk to be traded at 364.8 in 90 days.
  
Understanding current and past Phapros Tbk Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Phapros Tbk's financial statements are interrelated, with each one affecting the others. For example, an increase in Phapros Tbk's assets may result in an increase in income on the income statement.

Phapros Tbk Stock Summary

Phapros Tbk competes with Indofarma Tbk, Pyridam Farma, Itama Ranoraya, Darya Varia, and Kimia Farma. PT Phapros, Tbk operates in the pharmaceutical and health care industry in Indonesia. PT Phapros, Tbk operates as a subsidiary of PT Kimia Farma Tbk. Phapros Tbk operates under Drug ManufacturersSpecialty Generic classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 1568 people.
InstrumentIndonesia Stock View All
ExchangeJakarta Exchange
ISINID1000147507
Business AddressRajawali Tower 17th
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic
BenchmarkDow Jones Industrial
Websitewww.phapros.co.id
Phone62 21 576 2709
CurrencyIDR - Indonesian Rupiah
You should never invest in Phapros Tbk without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Phapros Stock, because this is throwing your money away. Analyzing the key information contained in Phapros Tbk's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Phapros Tbk Key Financial Ratios

Phapros Tbk's financial ratios allow both analysts and investors to convert raw data from Phapros Tbk's financial statements into concise, actionable information that can be used to evaluate the performance of Phapros Tbk over time and compare it to other companies across industries.

Phapros Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Phapros Tbk's current stock value. Our valuation model uses many indicators to compare Phapros Tbk value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Phapros Tbk competition to find correlations between indicators driving Phapros Tbk's intrinsic value. More Info.
Phapros Tbk PT is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about  1.57  of Return On Asset per Return On Equity. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Phapros Tbk's earnings, one of the primary drivers of an investment's value.

Phapros Tbk PT Systematic Risk

Phapros Tbk's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Phapros Tbk volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Phapros Tbk PT correlated with the market. If Beta is less than 0 Phapros Tbk generally moves in the opposite direction as compared to the market. If Phapros Tbk Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Phapros Tbk PT is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Phapros Tbk is generally in the same direction as the market. If Beta > 1 Phapros Tbk moves generally in the same direction as, but more than the movement of the benchmark.

Phapros Tbk November 29, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Phapros Tbk help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Phapros Tbk PT. We use our internally-developed statistical techniques to arrive at the intrinsic value of Phapros Tbk PT based on widely used predictive technical indicators. In general, we focus on analyzing Phapros Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Phapros Tbk's daily price indicators and compare them against related drivers.

Other Information on Investing in Phapros Stock

Phapros Tbk financial ratios help investors to determine whether Phapros Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Phapros with respect to the benefits of owning Phapros Tbk security.